Search research articles
Contact Us
Filters
Showing results (81-90 of 356) with videos related to
Page
of 36
Sort By:
Current Opinion in Pulmonary Medicine
|
July 5, 2012
The big clinical trials in idiopathic pulmonary fibrosis
Fabrizio Luppi, Paolo Spagnolo, Stefania Cerri, et al.
Orphanet Journal of Rare Diseases
|
October 19, 2012
Genetic testing in diffuse parenchymal lung disease
Paolo Spagnolo, Fabrizio Luppi, Stefania Cerri, et al.
The New England Journal of Medicine
|
October 1, 2025
Nerandomilast in Patients with Pulmonary Fibrosis. Reply
Toby M Maher, Luca Richeldi, Donald F Zoz
Seminars in Respiratory and Critical Care Medicine
|
February 18, 2009
Environmental triggers and susceptibility factors in idiopathic granulomatous diseases
Paolo Spagnolo, Luca Richeldi, Roland M du Bois
Expert Review of Respiratory Medicine
|
February 9, 2016
Novel drug targets for idiopathic pulmonary fibrosis
Giacomo Sgalla, Elisabetta Cocconcelli, Roberto Tonelli, et al.
Annals of the American Thoracic Society
|
July 2, 2020
Progressive Fibrosing Interstitial Lung Disease. A Proposed Integrated Algorithm for Management
Francesco Varone, Giacomo Sgalla, Bruno Iovene, et al.
Therapeutic Advances in Respiratory Disease
|
April 12, 2015
Nintedanib in the treatment of idiopathic pulmonary fibrosis
Mariano E Mazzei, Luca Richeldi, Harold R Collard
JAMA
|
May 9, 2023
The Future of Clinical Trials in Idiopathic Pulmonary Fibrosis
Anna J Podolanczuk, Luca Richeldi, Fernando J Martinez
Clinics in Chest Medicine
|
May 24, 2021
Looking Ahead: Interstitial Lung Disease Diagnosis and Management in 2030
Kerri A Johannson, Harold R Collard, Luca Richeldi
Expert Opinion on Pharmacotherapy
|
June 4, 2024
Promising advances in treatments for the management of idiopathic pulmonary fibrosis
Carmelo Sofia, Alessia Comes, Giacomo Sgalla, et al.
Page
of 36
Search research articles
Search
Showing results (81-90 of 356) with videos related to
Sort By:
Page
of 36
Current Opinion in Pulmonary Medicine
|
July 5, 2012
The big clinical trials in idiopathic pulmonary fibrosis
Fabrizio Luppi, Paolo Spagnolo, Stefania Cerri, et al.
Orphanet Journal of Rare Diseases
|
October 19, 2012
Genetic testing in diffuse parenchymal lung disease
Paolo Spagnolo, Fabrizio Luppi, Stefania Cerri, et al.
The New England Journal of Medicine
|
October 1, 2025
Nerandomilast in Patients with Pulmonary Fibrosis. Reply
Toby M Maher, Luca Richeldi, Donald F Zoz
Seminars in Respiratory and Critical Care Medicine
|
February 18, 2009
Environmental triggers and susceptibility factors in idiopathic granulomatous diseases
Paolo Spagnolo, Luca Richeldi, Roland M du Bois
Expert Review of Respiratory Medicine
|
February 9, 2016
Novel drug targets for idiopathic pulmonary fibrosis
Giacomo Sgalla, Elisabetta Cocconcelli, Roberto Tonelli, et al.
Annals of the American Thoracic Society
|
July 2, 2020
Progressive Fibrosing Interstitial Lung Disease. A Proposed Integrated Algorithm for Management
Francesco Varone, Giacomo Sgalla, Bruno Iovene, et al.
Therapeutic Advances in Respiratory Disease
|
April 12, 2015
Nintedanib in the treatment of idiopathic pulmonary fibrosis
Mariano E Mazzei, Luca Richeldi, Harold R Collard
JAMA
|
May 9, 2023
The Future of Clinical Trials in Idiopathic Pulmonary Fibrosis
Anna J Podolanczuk, Luca Richeldi, Fernando J Martinez
Clinics in Chest Medicine
|
May 24, 2021
Looking Ahead: Interstitial Lung Disease Diagnosis and Management in 2030
Kerri A Johannson, Harold R Collard, Luca Richeldi
Expert Opinion on Pharmacotherapy
|
June 4, 2024
Promising advances in treatments for the management of idiopathic pulmonary fibrosis
Carmelo Sofia, Alessia Comes, Giacomo Sgalla, et al.
Page
of 36